Plethora Solutions Ltd: Clinical Trials

5 trials sponsored by Plethora Solutions Ltd, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 3 Phase 1, 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3
Phase 22Completed 2
Phase 31Completed 1

Follow Plethora Solutions Ltd: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PSD502 in Subjects With Premature Ejaculation
Placebo, PSD502 - Premature Ejaculation
Phase 2CompletedPlethora Solutions Ltd1212018-12-262022-07-05
A Safety and Tolerability of PSD502 (a Topical Anesthetic) in the Treatment of Premature Ejaculation
Intervention A, Intervention B - Premature Ejaculation
Phase 1CompletedPlethora Solutions Ltd302010-09-012016-08-10
A Safety and Tolerability Study of Administration of PSD502
Intervention A, Intervention B, Intervention C - Premature Ejaculation
Phase 1CompletedPlethora Solutions Ltd212009-12-012016-08-10
Efficacy, Safety and Tolerability of PSD502 (a Topical Anesthetic) in the Treatment Premature Ejaculation
PSD502, contains a mixture of lidocaine and prilocaine, Placebo - Premature Ejaculation
Phase 2 / Phase 3CompletedPlethora Solutions Ltd2562007-10-012016-09-26
Phase I Study of PSD502 (Lidocaine Prilocaine Spray) Applied to the Glans Penis up to Three Times a Day for 21 Days in Healthy Male Volunteers
PSD502 - Healthy
Phase 1CompletedPlethora Solutions Ltd162007-03-012010-07-15

Conditions studied

Premature Ejaculation (4)

Interventions

Lidocaine, Prilocaine Drug Combination (3)  ·  Prilocaine (1)

Countries

United States (3)  ·  United Kingdom (1)

Top investigators

Culley Carson, MD (1)  ·  Jed Kaminetsky, MD, BA (1)  ·  Steven F. Komjathy, MD (1)